1 Min Read
LONDON, April 2 (Reuters) - AstraZeneca PLC : * US court says one Pulmicort patent invalid * Decision will not change AstraZeneca’s revenue guidance for 2013
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.